Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/c28a1de4-d485-455d-b927-eaa8ea7d6ba9/
RMD
ResMed IncSnapshot 2026-07-26 · 0.9w · Fresh
Strategy Eligibility
5 of 23 passing
★
OS Composite
✗
↗
Trending Value
✗
◆
Quality × Value
✗
🏛
Cornerstone Value
✗
🌿
Cornerstone Growth
✗
💎
Deep Value
✗
◇
VC2 Cheapest
✗
📐
EBITDA/EV
✗
◐
Veiled Value
✗
▣
Piotroski Bargains
✗
🔬
Quality Compounders
ROE 23%
📈
Consistent Earners
Yes
🌱
GARP
Rev +10%
🔄
Shareholder Yield
3.1%
💰
High Yield
✗
🚀
Momentum Leaders
✗
◉
Market Leaders
✗
◎
Tiny Titans
✗
🔍
Small Cap Value
✗
🛡
Low Volatility
✗
🏷
Sector Cheapest
✗
🧠
Capital Allocators
CAQ 0.82
⚡
Risk-Adj Momentum
✗
V
Value Analysis
Cheapness relative to fundamentals
25.0%ile
P/E
18.6×
P/S
5.1×
P/B
4.4×
E/P
0.0702
FCF Yield
0.074
EBITDA/EV
0.079
SH Yield
0.031
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
80.00000000
/100 — 1=cheapest
VC2 (Trending Value)
77.00000000
/100
VC3 (Buyback)
78.00000000
/100
FCF yield of 7.4% is strong — the business generates significant free cash relative to price.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
97.0%ile
ROE
0.234
ROA
0.173
Net Margin
0.274
Op Margin
0.349
GPA
0.389
D/E
0.35
Current
3.01
F-Score
8/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.103
Earn Growth
0.157
Stability
0.107
lower=better
Accruals
-0.042
lower=better
5yr Consist
Yes
ROE of 23% is exceptional. Conservative balance sheet with D/E of 0.35. F-Score of 8/9 indicates strong fundamental improvement across multiple dimensions.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
12.0%ile
6M Return
-22.2%
12M Return
-28.3%
12-1 Mom
-26.5%
Risk-Adj
-1.09
Vol 252d
24.3%
Vol 60d
56.0%
↑ Expanding
Max DD 12M
-35.3%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
12-1 momentum of -26% signals a downtrend — price is moving against you. Near-term vol (56%) is expanding vs long-term (24%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.29
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
▦
Sector Context
Healthcare
· 500 peers
Sector Value %ile
8.2%
Sector Quality %ile
97.4%
P/E z-score
-0.15
P/B z-score
-0.10
Sector Avg OS
64.9%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
Factor Interactions
Quality at a Premium
High quality (97th) but expensive (25th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (56%) significantly exceeds 252-day (24%). Near-term risk is elevated.
⚖
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
C
54.9% avg (7 factors)
Quality
A
87.4% avg (8 factors)
Momentum
F
2.9% avg (4 factors)
Risk
A
76.2% avg (1 factors)
Momentum is weak, suggesting the market isn't yet buying this thesis. Patience required.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Score Trends8 snapshots
Factor Persistence8 snapshots
| Factor | Current | Streak | Trend | Spark |
|---|---|---|---|---|
| OS Composite | 0.290 | —4 | — | |
| Value %ile | 0.250 | —8 | — | |
| Quality %ile | 0.970 | —8 | — | |
| Momentum %ile | 0.120 | —8 | — | |
| F-Score | 8.000 | —8 | — | |
| Confidence | 0.958 | —8 | — | |
| Volatility | 0.243 | —0 | — |
Value Lens2021-07-27 → 2026-07-26
P/E Ratio
Earnings Yield
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
18.64
Earnings Yield (E/P)
0.0702
Price / Sales
5.11
Price / Book
4.36
Price / Cash Flow
14.99
FCF Yield
7.4%
EBITDA / EV
7.9%
Sales Yield (1/P·S)
0.2013
Shareholder Yield
Div + net buyback / mktcap
3.1%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
23.4%
Return on Assets
17.3%
Net Margin
27.4%
Operating Margin
34.9%
Gross Profit / Assets
Novy-Marx GPA
38.9%
Debt / Equity
0.35
Current Ratio
3.01
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.042
External Financing
Net issuance — lower=better
0.077
MomentumPrice trend strength over different horizons
6M Return
-22.2%
12M Return
-28.3%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
-26.5%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
-1.09
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
10.3%
Earnings Growth (YoY)
15.7%
Earnings Stability (CV)
Lower = more stable
0.107
5yr Consistent
EPS up every year for 5 years
Yes
Piotroski F-Score
8
Dividend Yield
1.2%
Buyback Yield
1.9%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
80
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
77
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
78
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity